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Port wine stains (PWS) are congenital vascular
malformations characterized by multiple dilated
vessels in the dermis which become larger or more
ectatic with age. These lesions, which are benign,
disfiguring cutaneous vascular birthmarks, occur
with an incidence of 0.3% in the population.1–4
As two-thirds of these malformations occur on the
face, PWS are a clinically significant problem. PWS
should not only be considered a cosmetic prob-
lem per se, but a disease with potentially devas-
tating psychological and physical complications.
Personality development is adversely influenced
in virtually all patients by the negative reaction
of others to a “marked” person.5–7 In the initial
stages, most PWS appear as faint, pink macules,
but the lesions tend to darken progressively, dis-
playing a reddish-purplish nature.8 The subse-
quent hypertrophy of underlying bone and soft
tissue further disfigures the facial appearance of
many patients. Histopathologic studies of PWS
show a normal epidermis overlying an abnormal
plexus of subsurface blood vessels located in the
upper dermis. Vascular ectasia occurs in the most
superficial 800μm of the skin and involves mature
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Background/Purpose: Vascular ectasia observed in port wine stain (PWS) birthmarks might be secondary
to localized reduction of neural innervation and associated loss of autonomic stimulation. Our objective
was to investigate this theory and evaluate nerve density, blood vessel density, and average blood vessel
size in untreated and pulsed dye laser with cryogen spray cooling (PDL-CSC) treated PWS skin.
Methods: Biopsy skin specimens were taken from 14 adults with a PWS, categorized by: uninvolved skin;
untreated PWS skin; PWS skin with a history of good blanching, and PWS skin with a history of poor blanch-
ing both in response to PDL treatment. Seven specimens of normal, unaffected skin were used as the experi-
mental control group. Indirect immunohistochemistry was performed on all specimens followed by confocal
microscopy imaging with computer analysis to determine nerve density, blood vessel density, and average
blood vessel size.
Results: Nerve density was significantly decreased in all PWS sites as compared to uninvolved skin (p < 0.01).
Average blood vessel diameter was larger in untreated as compared to treated PWS sites and varied between
different sites within a single PWS.
Conclusion: Nerve density was decreased in all evaluated PWS sites, and this may be a factor in lesion
pathogenesis. PWS blood vessel size correlated with the PDL blanching response and may prove to be 
a useful prognostic indicator of therapeutic outcome. [J Formos Med Assoc 2008;107(7):559–566]
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dermal vessels that can be identified using 
immunohistochemistry.9
Previous studies proposed that the pathogen-
esis of PWS is related to a reduction in neural in-
nervation around the ectatic blood vessels.6–10 The
neural defect is likely to be autonomic in nature,
as there have not been cases of sensory loss experi-
enced by the patient affected by PWS. Blood flow
in the absence of tonic modulation is thought to
produce PWS vascular ectasia. Consistent with this
theory, ectasia is progressive with age, resulting
in lesion darkening from pink to purple hues.2
The development of lasers, namely their ability
to damage PWS blood vessels selectively, have un-
doubtedly offered a promising treatment option.
The pulsed dye laser (PDL)11–14 along with the
concept of selective photothermolysis15,16 signif-
icantly improved PWS treatment. Yellow light
(λ = 585–595 nm) emitted by the PDL is prefer-
entially absorbed by hemoglobin (the major chro-
mophore in blood) in the PWS vessels and, after
being converted to heat, causes thermal damage
and thrombosis. The PDL produces reasonably
good results in a select population of PWS patients
due to its ability to selectively destroy cutaneous
blood vessels.17–20 However, very few patients
achieve complete PWS blanching despite receiving
multiple laser treatments.21–24 Furthermore, while
there are some factors (including anatomic loca-
tion, size, color, nodularity, age) that appear to
influence treatment response, none of these have
been accepted as a reliable prognostic indicator of
therapeutic outcome to date.18
The purpose of our study was to compare 
average nerve density, blood vessel density, and
average blood vessel size in uninvolved versus in-
volved (lesion) skin from PWS patients to investi-
gate the proposed role of neural innervation. These
parameters were also compared between untreated
and treated PWS sites.
Methods
Twenty-one male subjects, aged from 18 to 58
years (mean age, 25.6 years), were included in this
study (IRB:96-0615C). Fourteen subjects had PWS
lesions on the face and had all received three sin-
gle PDL-CSC (cryogen spray cooling) treatments,
thus leaving the remaining seven patients with nor-
mal skin to serve as the study control group. The
parameters of PDL-CSC, ScleroPLUS® (Candela,
Wayland, MA, USA) PDL were as follows: 585 nm
wavelength, spot size 7 mm, pulse duration
(τp)1500 μs, and energy densities ranging from 
7 to 10 J/cm2. Cryogen spurt duration (30 ms) and
delay between cryogen delivery and laser irradia-
tion (20 ms) were controlled with a programmable
digital delay generator. PDL-CSC treatments were
administered at three intermittent intervals of 6–8
weeks, for a total of 6 months. The first treatment
of the series was given to 14 patients and there
was a 6–8 week interval before the second treat-
ment was undertaken. After the second and third
applications of the PDL-CSC treatment, record-
ing of the laser response was taken after another
6–8 weeks. Seven average, healthy volunteers were
used as the experimental control group. Skin biop-
sy specimens (3mm diameter punches) were taken
under local anesthesia (2% xylocaine) from the
following sites: normal skin (7 patients, 14 spec-
imens in total to use as a control); uninvolved skin
(14 patients, 14 specimens in total); pretreated
PWS skin with good blanching response (7 pa-
tients, 14 specimens); pretreated PWS skin with
a poor blanching response (7 patients, 14 speci-
mens); posttreatment PWS skin with a good
blanching response (7 patients, 14 specimens);
and posttreatment PWS skin with a poor blanch-
ing response (7 patients, 14 specimens). Based on
comparisons between the pre- and posttreatment
index of their hemoglobin, each patient’s PWS was
assigned a blanching response of “poor” when the
index was <25%. The DermaSpectrometer (Cortex
Technology, Smedevaenget 10, 9560 Hadsund,
Denmark)25 performed calculations of the index
of hemoglobin and concurred that 14 PWS speci-
mens had physical signs of a good blanching 
response (index of hemoglobin > 25%).
Specimens were fixed and sectioned, and im-
munohistochemical staining for pan-neuronal and
pan-endothelial markers was performed according
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to the compulsory protocol. Specimens were im-
mediately fixed in cold (4°C) Zamboni’s fixative24
and left overnight. The next day, specimens were
transferred to 20% sucrose phosphate-buffered
saline (PBS) and refrigerated for 24 hours (or until
processing). Thick (100μm) sections were cut with
a frozen, sliding microtome (American Optical
Co., Buffalo, NY, USA), placed in spot plates (petri
dishes), and flooded with 0.05mol/L PBS (pH 7.4)
containing 0.3% Triton-X-100 (PBS/TX) (Sigma
Chemical Co., St. Louis, MO, USA) and 5% nor-
mal donkey serum (NDS) as a blocking serum for
1 hour to avoid nonspecific background staining.
Subsequently, the floating sections were incubated
for 16 hours at 4°C on a rotating table with the
following primary antibodies: (a) pan-neuronal
marker for nerves, protein gene product 9.5 (PGP
9.5)26 (Ultraclone, Wellow, UK) at a working dilu-
tion of 1:1000; and (b) pan-endothelial marker
CD31 (Dako Corp., Carpinteria, CA, USA)27 at a
working dilution of 1:80.
Primary antibodies were visualized with cya-
nine 2 or cyanine 3.18 fluorophores conjugated
to the appropriate mouse or rabbit secondary an-
tibodies (Jackson Immunoresearch, West Grove,
PA, USA). For secondary antibodies, floating sec-
tions were incubated overnight at 4°C on a rotat-
ing table and then washed with 1% NDS in PBS/TX
for four successive incubations. Washed sections
were mounted without drying on coverslips, de-
hydrated in alcohol, cleared with methyl salicy-
late (Fisher Scientific, Pittsburgh, PA, USA), and
mounted in DPX (a mixture of distyrene, a plasti-
cizer, and xylene) (Fluka, Ronkonkoma, NY, USA)
for microscopy.
Specimens were initially examined with a
Nikon (Melville, NY, USA) epifluorescence mi-
croscope. The sections were then imaged with an
MRC-1000 scanning confocal microscope system
equipped with a krypton/argon ion laser (Bio-
Rad Life Science, Hercules, CA, USA). A series of
optical sections (20× magnification) were acquired
at 2 μm intervals through the entire thickness of
the specimen (approximately 60μm) and then pro-
jected into a single-focus image with the software
supplied (Confocal Assistant 4.02, a free 2D and
3D animation software created and copyrighted
by Todd Clark Brelje).
The densities of nerves and blood vessels (μm3/
μm3 tissue) were quantified for all samples using
the three-dimensional software Image3 LLC
Velocity2 Pro (Salt Lake City, UT, USA). This soft-
ware uses the digital images acquired by the con-
focal microscope to create a three-dimensional
model of the nerves and blood vessels, which can
then be used to calculate density values. Measure-
ments of blood vessel diameters were made for
all samples using the public domain NIH Image
program (U.S. National Institutes of Health, avail-
able on the Internet at: http://rsb.info.nih.gov/
nih-image/). Measurements were taken of the di-
ameter of the dermal vessels (superficial or deep)
in four random, 20× magnification fields per skin
biopsy sample.
Nerve density and blood vessel density of un-
involved skin of PWS subjects were compared to
that of normal healthy skin in our controls along
with untreated PWS facial sites (Table). Then 
following PDL-CSC treatment of these groups,
these calculations were further compared between
the PWS skin specimens with a history of good
blanching in response to PDL treatments, along
with those that had a history of poor blanching
response to PDL treatments. Once determination
of blanching response was recorded, specimens
from skin with a good blanching history and with
a poor blanching history were further analyzed
for consistency in the PDL-CSC response.14,24,28
Statistical analysis was performed and recorded
after the third intermittent interval using a two-
sample Student’s t test by means of the computer
software Stat View® version 5.0.1. (SAS Institute
Inc., Cary, NC, USA).
Results
Papillary and reticular dermal blood vessels 
were included for calculation of average vessel
diameters (Table). Uninvolved skin from PWS
patients had average nerve and blood vessel den-
sities of 18.51 ± 1.02 × 10−3 μm3/μm3 tissue and
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6.74±0.35×10−3 μm3/μm3, respectively. These val-
ues were not statistically different from samples
of the control group (normal skin) where aver-
age nerve and blood vessel densities were 11.87 ±
0.72 × 10−3 μm3/μm3 and 6.39 ± 0.31 × 10−3 μm3/
μm3 respectively. The average blood vessel diam-
eter in uninvolved skin from PWS patients was
15.53 ± 0.94 μm with a range of 6.38 ± 0.30 to
28.91 ± 1.43 μm (Table; Figures 1A and 1B). Nerve
density was significantly decreased (range, 0.38–
1.92 × 10−3 μm3/μm3) in all PWS sites as com-
pared to the net results observed in uninvolved
skin specimens (p < 0.01). Blood vessel density
was variable as described below. Average blood
vessel diameter was greater in all PWS sites as
compared to that of uninvolved skin. Histologic
C.J. Chang, et al
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Table. Blood vessel and nerve density findings*
Biopsy group/skin Nerve density Blood vessel density Blood vessel diameter 
categorizations (10−3 μm3/μm3 tissue) (10−3 μm3/μm3 tissue) (μm)
Control group w/normal 11.87 ± 0.72 6.39 ± 0.31 17.33 ± 0.98 (7.82 ± 0.41 to 30.01 ± 1.52)
healthy skin (n = 14)
Uninvolved skin of PWS 18.51 ± 1.02 6.74 ± 0.35 15.53 ± 0.94 (6.38 ± 0.30 to 28.91 ± 1.43)
patients (n = 14)
Pretreated PWS: 
blanching response
Good (n = 14) 0.81 ± 0.36† 22.37 ± 1.36† 57.85 ± 2.15 (8.65 ± 0.53 to 189.58 ± 6.14)
Poor (n = 14) 0.65 ± 0.02† 24.71 ± 1.52 87.72 ± 3.21 (28.23 ± 1.31 to 227.81 ± 13.26)
Posttreatment PWS: 
blanching response
Good (n = 14) 1.92 ± 0.06† 6.93 ± 0.37 28.53 ± 1.56 (8.67 ± 0.55 to 81.35 ± 3.17)
Poor (n = 14) 0.38 ± 0.01† 31.94 ± 1.96† 49.37 ± 2.03 (26.93 ± 1.17 to 283.05 ± 18.03)
*Data presented as mean ± standard deviation or mean ± standard deviation (range); †p < 0.01 vs. uninvolved skin.
A B
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Figure 1. (A) Confocal images from normal healthy volun-
teer skin showing the capillaries stained with CD31 (red)
and nerves stained with PGP 9.5 (green). ENF = epidermal
nerve fibers; DNF = dermal nerve fibers. (B) Untreated site
of PWS with a history of good blanching in response to
PDL treatment. (C) Untreated site of PWS with a history of
poor blanching in response to PDL treatment.
examination of pretreatment PWS sites of patients
revealed a decrease in nerve density as compared
to uninvolved skin from the same patient. Aver-
age nerve density in the pretreated sites of the
poor blanching response lesions was 0.65 ± 0.02 ×
10−3 μm3/μm3. Blood vessel density was increased
in pretreated PWS specimens to 24.71 ± 1.52 ×
10−3 μm3/μm3. Average vessel diameter was in-
creased in pretreated PWS specimens with poor
blanching response and had an average vessel 
diameter of 87.72 ± 3.21 μm.
The DermaSpectrometer was used on the pa-
tients to determine the extent of blanching re-
sponse, and, based on comparisons between the
pre- and posttreatment index of their hemoglobin,
each patient’s PWS was assigned a blanching re-
sponse, with “poor” when the index was < 25%.
The instrument took calculations of the index 
of posttreatment hemoglobin and concurred that
14 PWS specimens had physical signs of a good
blanching response (index of hemoglobin >25%),
due to a decrease in the average nerve density of
1.92 ± 0.06 × 10−3 μm3/μm3 (p < 0.01) while there
was a relatively normal blood vessel density
(mean, 6.93 ± 0.37 × 10−3 μm3/μm3) as compared
to that of the uninvolved skin (Table; Figures 2A–C
and 3A–C). Blood vessel diameter was relatively
normal as compared to that in uninvolved skin
(Table). The range of blood vessel diameters for
these patients was 8.67 ± 0.55 to 81.35 ± 3.17 μm
(mean, 28.53 ± 1.56 μm). In all cases, use of PDL-
CSC treatment was administered on each patient
a total of three times to determine the effects of
the laser on the PWS affected area.
Of the above mentioned 14 patients, the
DermoSpectrometer further concluded that seven
patients showed physical signs of poor blanching
in response to PDL-CSC treatment. These seven
patients had experienced a decrease in average
nerve density of 0.38 ± 0.01 × 10−3 μm3/μm3 (p <
0.01) and increased average blood vessel density
of 31.94 ± 1.96 × 10−3 μm3/μm3 (p < 0.01) as com-
pared to the skin of uninvolved subjects (Table).
Blood vessels were also enlarged as compared to
uninvolved skin samples (Table; Figure 1). The
range of blood vessel diameters was 26.93 ± 1.17
to 283.05 ± 18.03 μm (mean, 49.37 ± 2.03 μm).
Again, in all cases, use of PDL-CSC treatment
was administered to each patient a total of three
times over the course of about 6 months to 
determine the effects of the laser on the PWS 
affected area.
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Figure 2. (A) Uninvolved skin of a PWS patient. (B) PWS
with a history of good blanching in response to PDL treat-
ment (before treatment). (C) PWS with a history of poor
blanching in response to PDL treatment (before treatment).
Note the very large vascular ectasia and the presence of
only two nerves in the field (magnification, 20×).
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Discussion
PWS are progressive vascular lesions composed
of ectatic dermal capillaries.2 As expected, our
data found the average blood vessel diameter to
be larger in all PWS sites as compared to those of
uninvolved skin. The pathogenesis of this vascular
dilatation is unknown, but previous studies have
proposed a reduction in neural innervation in
areas of skin with PWS involvement.5–7 Our confo-
cal images confirmed a significant decrease in
nerve density from samples of both pretreated and
posttreated (p < 0.01) PWS skin compared to un-
involved skin. Our findings add support to the the-
ory that PWS vascular ectasia may result from
decreased neural innervation. From the tabulated
results, it can be seen that as nerve density de-
creased the blood vessel diameter increased
(Table). However, other possible explanations can-
not be ruled out including the influence of a local-
ized third factor (e.g. cytokine), which could form
during fetal development, promoting both vessel
dilatation and inhibition of nerve development.
It is interesting to note the proposed role for de-
creased nerve density in lesion pathogenesis may
be unique to PWS as compared to other vascular
lesions. Different mechanisms have been proposed
for the development of other vascular entities such
as hemangiomas.29 Further study is required.
Although the numbers of PDL-CSC treatments
were the same, PWS of the two laser-treated
groups (good blanching versus poor blanching)
had contrasting results. The correlation between
posttreatment blood vessel size and therapeutic
outcome was consistent. Average vessel diameter
was larger in areas with a history of poor blanch-
ing in response to PDL-CSC treatment as com-
pared to areas with a good blanching response.
This reaction may be due to the excessively large
vessels requiring prolonged pulsed duration, pos-
ing difficulties in accurate photocoagulation. This
relationship may be useful from a predictive
standpoint as noninvasive imaging of PWS and
determination of average blood vessel diameter
prior to treatment may be used as a prognostic
indicator of therapeutic outcome. Patient age and
a number of PWS characteristics such as size, color
and anatomic location have been considered as
prognostic indicators of PDL-CSC therapy. How-
ever, to date, none of these variables have been
accepted as a reliable indicator of therapeutic
outcome.
A B
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Figure 3. (A) Involved skin of a PWS patient. (B) PWS with
good blanching in response to PDL treatment (after treat-
ment). (C) PWS with poor blanching in response to PDL
treatment (after treatment).
Our data also revealed a trend towards larger
vessels in pretreated versus posttreated PWS sites.
As there were no pretreatment biopsies, we were
unable to determine from this study if the decrease
in average vessel size in treated PWS was a result of
laser therapy. However, we believe this to be a like-
ly explanation, which should be explored in future
prospective studies.
In facial PWS, average vessel diameter varied
depending on the location and size of the affected
area. Variations in vessel size within the PWS have
important implications for laser treatment. Cur-
rently, medical specialists most often treat an en-
tire PWS lesion with identical laser parameters
such as wavelength, pulse duration, energy density,
and CSC (with use of spurt duration applica-
tion).30 However, PWS blood vessel size and depth
affect the optical absorption and scattering prop-
erties of the skin and, if these factors vary, laser
parameter adjustments for different areas within
a lesion is likely to be beneficial. Diagnostic im-
aging methods for PWS characterization such as
infrared tomography and optical Doppler tomog-
raphy are being evaluated as a means of rapidly
and noninvasively determining blood vessel size
and depth to optimize laser treatment parame-
ters on a site-to-site basis.31–33
In conclusion, nerve density was decreased 
in all evaluated PWS sites, and this may be a fac-
tor in lesion pathogenesis. PWS blood vessel size
correlated with the blanching response of PDL
treatment and may prove to be a useful prog-
nostic indicator of therapeutic outcome. Our ex-
perimental results will be confirmed in a larger
study in which we will follow serial biopsies 
(beginning at pretreatment) from multiple PWS
sites obtained from both the same and different
individuals.
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